403. Influence of a 12-week Facial Protective Equipment (FPE) wearing period on the behaviors and attitudes towards FPE use among healthcare personnel (HCP)
Session: Poster Abstract Session: Occupational Health
Thursday, October 3, 2013
Room: The Moscone Center: Poster Hall C
Background: FPE is recommended to prevent occupational transmission of acute respiratory illnesses (ARI) among HCP. We aim to determine if attitudes of HCP changed after a 12-week period of FPE use among participants in the Respiratory Protection Effectiveness Clinical Trial (ResPECT).

Methods: ResPECT compares the effectiveness of medical masks and N95 respirators for prevention of ARI in outpatient HCP. Participants were asked to wear FPE when within 6 feet of patients (pts) with respiratory (resp) symptoms during a 12-week peak period of local influenza activity. They were also asked about their baseline behavior and post-study attitudes towards both FPE in a pre- and post-study survey.

Results: Of 1077 HCP who completed the study, 1011 (94%) answered both pre- and post-study surveys. The percentage of HCP who wear and plan to wear FPE with patient contact significantly increased. Reasons to wear and not to wear FPE changed with study participation. Data was analyzed using Chi-square and McNemar tests.

 

 

Questions

 

Masks n (%)

 

N95 n (%)

 

Pre-study

Post-study

p

Pre-study

Post-study

p

Wear/plan to wear FPE

N=1011

<0.0001

N=1011

<0.0001

Every pt

79(8)

154(15)

 

12(1)

49(5)

 

Some pts

771(76)

790(78)

 

512(51)

698(69)

 

Never

156(15)

49(5)

 

476(47)

210(21)

 

No response

    5(<1)

18(2)

 

11(1)

54(5)

 

 

 

 

 

 

 

 

Reasons to wear FPE

N=971

 

N=733

 

Avoid getting resp infections

598(62)

695(72)

<0.0001

239(33)

420(57)

<0.0001

Avoid spreading resp pathogens among pts

  513(53)

   510(53)

   0.8618

  170(23)

   302(41)

<0.0001

Avoid spreading resp pathogens to family

473(49)

473(49)

1.0000

156(21)

286(39)

<0.0001

Required to wear by supervisor, occupational health, or clinic policy

  289(30)

   277(29)

 0.4515

  111(15)

   194(26)

<0.0001

 

 

 

 

 

 

 

Reasons to not wear FPE

N=1011

 

N=1011

 

Uncomfortable/Difficulty breathing

353(35)

124(12)

<0.0001

383(38)

243(24)

<0.0001

Interferes with communication

377(37)

106(10)

<0.0001

321(32)

173(17)

<0.0001

Unavailable

342(34)

85(8)

<0.0001

332(33)

103(10)

<0.0001

Don't protect from infections

47(5)

13(1)

<0.0001

22(2)

10(1)

  0.0339

Other

65(6)

31(3)

 0.0002

54(5)

33(3)

 0.0196

Bonferroni’s correction=0.0025

Conclusion: In this trial, HCP attitudes significantly improved towards greater acceptance for both FPE use. Hospital administrators and healthcare agencies could use this data to enhance FPE use in endemic and epidemic situations.

Mahwish Mushtaq, MD, MPH1,2, Michlene Daniels, BS1,2, Martha Zorn, MS3, Mary Bessesen, MD4, Cynthia Gibert, MD, MSc5, Ann-Christine Nyquist, MD, MSPH6, Trish M. Perl, MD, MSc, FIDSA, FSHEA7, Connie S. Price, MD8, Lewis J. Radonovich, MD9, Michael S. Simberkoff, MD10, Maria C. Rodriguez-Barradas, MD11 and The ResPECT Study Team, (1)Medicine-Infectious Disease, Baylor College of Medicine, Houston, TX, (2)Medicine-Infectious Disease, Michael E. DeBakey VA Medical Center, Houston, TX, (3)University of Massachusetts, Amherst, MA, (4)Infectious Diseases, University of Colorado Denver, Aurora, CO, (5)Washington, DC, VAMC, Washington, DC, (6)University of Colorado, Denver, CO, (7)Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, (8)Denver Health Medical Center, Denver, CO, (9)University of Florida College of Medicine, Gainesville, FL, (10)VA NY Harbor Healthcare System, New York, NY, (11)Infectious Diseases and Medicine, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX

Disclosures:

M. Mushtaq, None

M. Daniels, None

M. Zorn, None

M. Bessesen, None

C. Gibert, None

A. C. Nyquist, None

T. M. Perl, None

C. S. Price, None

L. J. Radonovich, None

M. S. Simberkoff, None

M. C. Rodriguez-Barradas, None

See more of: Occupational Health
See more of: Poster Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.